Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-1712 | Report Format : | Status : Upcoming |

Abstract

Global Sickle Cell Anemia Treatment Market: Overview

A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal conditions, the red blood cells move easily through the blood vessels and are flexible round in shape. When one is suffering from sickle cell anemia the red blood cells become rigid and sticky and are sickle shaped. Thus, these red blood cells block the flow of oxygen and blood to the other parts of the body by getting stuck in the blood vessels. Mutation in the gene causes sickle cell anemia.

Global Sickle Cell Anemia Treatment Market: Segmentation

The market for the sickle cell anemia treatment is globally fragmented into therapy type and distribution channels. Depending on the therapy type, the global market is segregated into bone marrow transplant, medications, blood transfusion, and gene therapy. The medications segment is further sub-segmented into antimetabolites, vaccines, antibiotics, analgesics, and folic acid. According to the end user, the market is categorized into clinics, hospitals, and home healthcare.

Global Sickle Cell Anemia Treatment Market: Growth Factors

The occurrence of the sickle cell anemia disease is increasing in under-developed, developing, and the developed regions; this high prevalence of the disease in the regions is driving the market. The other factors that are contributing to the market growth are the growing needs that are not satisfied, the increasing product pipeline for the treatment of the sickle cell anemia are projecting to create a high requirement for options of treatment. Sickle cell anemia treatment market is growing owing to the rising support by the governments and the regulatory bodies which are by means of the investments that are made in the activities of research and development and the approval for developing and finding new treatment options for this disease is very fast. The factors that are restraining the sickle cell anemia treatment market growth are the adoption of the treatments is slow this is owing to the cost related with it, permanent cure for sickle cell anemia disease is absent, and the treatment is a complex procedure.

Global Sickle Cell Anemia Treatment Market: Regional Analysis

The geographical segmentation of the global key opinion leader management market is diversified into Western Europe, Eastern Europe, Latin America, North America, the Middle East and Africa, and Asia Pacific. The region that is dominating the sickle cell anemia treatment market is the North America. Factors that are contributing to the market growth are increasing activities in the research and development, accessibility to developed healthcare infrastructure, and favorable reimbursement policies attribute the region to contribute a larger market share. The high prevalence of the disease in the African and Asia-Pacific regions is favoring the sickle cell anemia treatment market growth in these regions.

Global Sickle Cell Anemia Treatment Market: Competitive Players

The key market players that are involved in the sickle cell anemia market include Bluebird Bio, Eli Lilly, Gilead Sciences, Inc., Merck & Co., Inc., Novartis AG, Sanofi, Baxter, Bristol-Myers Squibb Company, Global Blood Therapeutics, Johnson & Johnson, Mast Therapeutics, and Pfizer, Inc.

Global Sickle Cell Anemia Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.